A new pet for myeloma.

IF 23.1 1区医学 Q1 HEMATOLOGY Blood Pub Date : 2009-09-03 DOI:10.1182/blood-2009-06-224196

Meletios-Athanassios Dimopoulos, Lia A Moulopoulos, Evangelos Terpos

引用次数: 6

Abstract

In this issue of Blood, Bartel and colleagues report the independent predictive value of the PET/CT and of the FDG suppression before transplantation in newly diagnosed myeloma patients who were treated using the TT3 regimen.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

骨髓瘤的新宠物。

在这一期的《Blood》杂志上，Bartel及其同事报道了PET/CT和移植前FDG抑制在新诊断的骨髓瘤患者中使用TT3方案治疗的独立预测价值。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Blood 医学-血液学

CiteScore

23.60

自引率

3.90%

发文量

955

审稿时长

1 months

期刊介绍： Blood, the official journal of the American Society of Hematology, published online and in print, provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology. Primary research articles will be published under the following scientific categories: Clinical Trials and Observations; Gene Therapy; Hematopoiesis and Stem Cells; Immunobiology and Immunotherapy scope; Myeloid Neoplasia; Lymphoid Neoplasia; Phagocytes, Granulocytes and Myelopoiesis; Platelets and Thrombopoiesis; Red Cells, Iron and Erythropoiesis; Thrombosis and Hemostasis; Transfusion Medicine; Transplantation; and Vascular Biology. Papers can be listed under more than one category as appropriate.

期刊最新文献

De novo CD19- B-ALL: awareness of a rare entity in initial diagnosis. Glutathionylated leaky mitochondrial pores as target in AML. Dysbiosis and gastrointestinal GVHD: to treat or not to treat. A viral Achilles' heel for EBV-positive lymphomas. Pediatric hospital-acquired thrombosis: time for a CHAT.